FinnCap reaffirmed their corporate rating on shares of Cambridge Cognition (LON:COG) in a research report report published on Thursday, ThisIsMoney.Co.Uk reports.

Shares of COG opened at GBX 26.50 ($0.35) on Thursday. Cambridge Cognition has a 1 year low of GBX 23.92 ($0.31) and a 1 year high of GBX 148.89 ($1.95). The stock has a 50 day simple moving average of GBX 49.37 and a 200-day simple moving average of GBX 64.98. The stock has a market cap of $6.41 million and a PE ratio of -3.79.

About Cambridge Cognition

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops digital health products. The company offers CANTAB Recruit, an online patient recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from phases I–IV or a cognitive testing software that enhances the chances of success and minimizing the risk of failure in neuroscience research; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps to provide engaging digital health solutions for the enhancement of patient engagement, demonstration of treatment efficacy, and understanding of a disease and a patient's response to medication.

Further Reading: What is a good rate of return for a mutual fund?

Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.